UBS Group’s VEON VEON Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $797K | Buy |
17,217
+7,582
| +79% | +$399K | ﹤0.01% | 5727 |
|
|
2025
Q4 | $507K | Buy |
9,635
+203
| +2% | +$10.3K | ﹤0.01% | 6082 |
|
|
2025
Q3 | $513K | Sell |
9,432
-15,096
| -62% | -$809K | ﹤0.01% | 6076 |
|
|
2025
Q2 | $1.13M | Buy |
24,528
+15,002
| +157% | +$690K | ﹤0.01% | 5341 |
|
|
2025
Q1 | $415K | Buy |
9,526
+2,129
| +29% | +$94.6K | ﹤0.01% | 5995 |
|
|
2024
Q4 | $297K | Buy |
7,397
+1,326
| +22% | +$44K | ﹤0.01% | 6206 |
|
|
2024
Q3 | $185K | Sell |
6,071
-334
| -5% | -$9.2K | ﹤0.01% | 5937 |
|
|
2024
Q2 | $166K | Buy |
6,405
+402
| +7% | +$10.1K | ﹤0.01% | 5793 |
|
|
2024
Q1 | $144K | Sell |
6,003
-1,161
| -16% | -$25.9K | ﹤0.01% | 6050 |
|
|
2023
Q4 | $141K | Buy |
7,164
+269
| +4% | +$4.99K | ﹤0.01% | 5985 |
|
|
2023
Q3 | $134K | Buy |
6,895
+29
| +0.4% | +$519 | ﹤0.01% | 5644 |
|
|
2023
Q2 | $140K | Hold |
6,866
| – | – | ﹤0.01% | 5740 |
|
|
2023
Q1 | $122K | Sell |
6,866
-1
| -0% | -$16 | ﹤0.01% | 5768 |
|
|
2022
Q4 | $84.1K | Hold |
6,867
| – | – | ﹤0.01% | 6266 |
|
|
2022
Q3 | $55K | Buy |
6,867
+1,267
| +23% | +$13.9K | ﹤0.01% | 6267 |
|
|
2022
Q2 | $65K | Sell |
5,600
-5,172
| -48% | -$69K | ﹤0.01% | 5729 |
|
|
2022
Q1 | $184K | Buy |
10,772
+6,121
| +132% | +$166K | ﹤0.01% | 5433 |
|
|
2021
Q4 | $199K | Sell |
4,651
-187
| -4% | -$9.12K | ﹤0.01% | 5692 |
|
|
2021
Q3 | $252K | Sell |
4,838
-91,730
| -95% | -$4.41M | ﹤0.01% | 5162 |
|
|
2021
Q2 | $4.42M | Sell |
96,568
-141,998
| -60% | -$6.27M | ﹤0.01% | 2821 |
|
|
2021
Q1 | $10.6M | Buy |
238,566
+144,793
| +154% | +$6.35M | ﹤0.01% | 1910 |
|
|
2020
Q4 | $3.54M | Sell |
93,773
-2,008
| -2% | -$71.5K | ﹤0.01% | 2816 |
|
|
2020
Q3 | $3.02M | Sell |
95,781
-185
| -0.2% | -$7.12K | ﹤0.01% | 2672 |
|
|
2020
Q2 | $4.32M | Sell |
95,966
-2,437
| -2% | -$98K | ﹤0.01% | 2155 |
|
|
2020
Q1 | $3.71M | Buy |
98,403
+1,540
| +2% | +$84.7K | ﹤0.01% | 2181 |
|
|
2019
Q4 | $6.13M | Buy |
96,863
+371
| +0.4% | +$22.8K | ﹤0.01% | 2416 |
|
|
2019
Q3 | $5.79M | Sell |
96,492
-219
| -0.2% | -$15K | ﹤0.01% | 2240 |
|
|
2019
Q2 | $6.77M | Buy |
96,711
+374
| +0.4% | +$22.4K | ﹤0.01% | 2083 |
|
|
2019
Q1 | $5.03M | Buy |
96,337
+228
| +0.2% | +$14.2K | ﹤0.01% | 2198 |
|
|
2018
Q4 | $5.62M | Buy |
96,109
+43,059
| +81% | +$2.91M | ﹤0.01% | 2043 |
|
|
2018
Q3 | $3.85M | Buy |
53,050
+51,332
| +2,988% | +$3.72M | ﹤0.01% | 2594 |
|
|
2018
Q2 | $102K | Sell |
1,718
-1,427
| -45% | -$89.3K | ﹤0.01% | 5430 |
|
|
2018
Q1 | $208K | Buy |
3,145
+982
| +45% | +$82.3K | ﹤0.01% | 4759 |
|
|
2017
Q4 | $208K | Sell |
2,163
-85
| -4% | -$8.31K | ﹤0.01% | 4875 |
|
|
2017
Q3 | $235K | Buy |
2,248
+112
| +5% | +$11.4K | ﹤0.01% | 4738 |
|
|
2017
Q2 | $209K | Sell |
2,136
-444
| -17% | -$43.8K | ﹤0.01% | 4716 |
|
|
2017
Q1 | $263K | Buy |
2,580
+1,917
| +289% | +$197K | ﹤0.01% | 4470 |
|
|
2016
Q4 | $64K | Sell |
663
-156
| -19% | -$13.5K | ﹤0.01% | 5633 |
|
|
2016
Q3 | $71K | Sell |
819
-678
| -45% | -$68.1K | ﹤0.01% | 5233 |
|
|
2016
Q2 | $145K | Buy |
1,497
+304
| +25% | +$28.5K | ﹤0.01% | 4769 |
|
|
2016
Q1 | $127K | Sell |
1,193
-1,976
| -62% | -$175K | ﹤0.01% | 4801 |
|
|
2015
Q4 | $261K | Sell |
3,169
-4,371
| -58% | -$395K | ﹤0.01% | 4472 |
|
|
2015
Q3 | $776K | Sell |
7,540
-6,768
| -47% | -$845K | ﹤0.01% | 3573 |
|
|
2015
Q2 | $1.78M | Sell |
14,308
-11,658
| -45% | -$1.65M | ﹤0.01% | 3088 |
|
|
2015
Q1 | $3.4M | Sell |
25,966
-6,388
| -20% | -$754K | ﹤0.01% | 2423 |
|
|
2014
Q4 | $3.38M | Buy |
+32,354
| New | +$4.39M | ﹤0.01% | 2418 |
|
Other funds holding VEON
LIM
SCM
SAAM
PC
VAS
UBS Group's VEON Position: Q1 2026 in Review
UBS Group increased its VEON (VEON) stake by 79% in Q1 2026, buying an estimated $399K and bringing the position to 17,217 shares worth $797K. The position accounts for ﹤0.01% of the portfolio, ranked #5727.
UBS Group first reported a position in VEON in Q4 2014 and has held it in 46 quarters since. The position peaked at $10.6M in Q1 2021. 101 funds tracked by Wall St. Rank hold VEON as of Q1 2026.
- UBS Group held 17,217 shares of VEON worth $797K as of Q1 2026.
- UBS Group bought 7,582 VEON shares in Q1 2026, an estimated $399K.
- VEON made up ﹤0.01% of UBS Group's portfolio in Q1 2026, its #5727 holding.
- UBS Group first reported a position in VEON in Q4 2014 and has held it in 46 quarters since.
- UBS Group's VEON position peaked at $10.6M in Q1 2021.
- 101 funds tracked by Wall St. Rank held VEON as of Q1 2026.
Based on UBS Group's 13F filing for Q1 2026, filed 5 May 2026.